Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

Blood - 8 Dec 2016

El Chaer Firas, Shah Dimpy P, Chemaly Roy F

Abstract excerpt

Cytomegalovirus (CMV) infection is a significant complication in hematopoietic cell transplantation (HCT) recipients. Four antiviral drugs are used for preventing or treating CMV: ganciclovir, valganciclovir, foscarnet, and cidofovir. With prolonged and repeated use of these drugs, CMV can become resistant to standard therapy, resulting in increased morbidity and mortality, especially in HCT recipients. Antiviral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus
Share to Cytomegalovirus Infections
Share to DNA-Directed DNA Polymerase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to Hematopoietic Stem Cell Transplantation

Share to Phosphotransferases (Alcohol Group Acceptor)

Share to Viral Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 27760756
DOI: 10.1182/blood-2016-06-688432
PMCID: PMC5146744

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.PMID 27760756Read ↗

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.Semantic proximity Read ↗

Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Approach to drug-resistant cytomegalovirus in transplant recipients.Semantic proximity Read ↗

Maribavir use in practice for cytomegalovirus infection in French transplantation centers.Semantic proximity Read ↗

Study of cytomegalovirus resistance in allogeneic hematopoietic cell transplant recipients.Semantic proximity Read ↗

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.Semantic proximity Read ↗

American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy RecipientsSemantic proximity Read ↗

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.Semantic proximity Read ↗

Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.